Evidence map›Paper›PMID 23621904›Full record

ArticleEmerging infectious diseases2013

Virulence of pertactin-negative Bordetella pertussis isolates from infants, France.

Hélène Bodilis, Nicole Guiso

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pertactin deficiency ofHuman vaccines & immunotherapeutics · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2025
    Article
  6. Pathogens and global health · 2023
    Review
  7. Can vaccines control bacterial virulence and pathogenicity?Evolution, medicine, and public health · 2022
    Review
  8. Article
  9. Evolution ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  10. Fha DeficientIranian journal of public health · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Bordetella pertussis: new concepts in pathogenesis and treatment.Current opinion in infectious diseases · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hélène BodilisInstitut Pasteur, Paris, France.
Nicole Guiso
Institut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants <6 months old infected by PRN-positive or PRN-negative isolates. No major clinical differences were found between the 2 groups.

Indexed as

Bacterial Outer Membrane ProteinsBacterial VaccinesBordetella pertussisFemaleFranceHumansInfantMaleMass VaccinationSurveys and QuestionnairesVirulenceVirulence Factors, BordetellaWhooping CoughBacterial Outer Membrane ProteinsBacterial VaccinespertactinVirulence Factors, Bordetellaacellular vaccinesbacteriaBordetella pertussiscoccobacillusimmunizationpertactinvaccinationvaccine

Identifiers

PMID23621904
PMCPMC3647673
OpenAlexW2079061335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.